Details

Autor(en) / Beteiligte

• Kallás, Esper G.
• Cintra, Monica A.T.
• Moreira, José A.
• Patiño, Elizabeth G.
• Braga, Patricia Emilia
• Tenório, Juliana C.V.
• Infante, Vanessa
• Palacios, Ricardo
• de Lacerda, Marcus Vínicius Guimarães
• Pereira, Dhelio Batista
• da Fonseca, Allex Jardim
• Gurgel, Ricardo Queiroz
• Coelho, Ivo Castelo-Branco
• Fontes, Cor Jesus Fernandes
• Marques, Ernesto T.A.
• Romero, Gustavo Adolfo Sierra
• Teixeira, Mauro Martins
• Siqueira, André M.
• Barral, Aldina Maria Prado
• Boaventura, Viviane Sampaio
• Ramos, Fabiano
• Elias Júnior, Erivaldo
• Cassio de Moraes, José
• Covas, Dimas T.
• Kalil, Jorge
• Precioso, Alexander Roberto
• Whitehead, Stephen S.
• Esteves-Jaramillo, Alejandra
• Shekar, Tulin
• Lee, Jung-Jin
• Macey, Julieta
• Kelner, Sabrina Gozlan
• Coller, Beth-Ann G.
• Boulos, Fernanda Castro
• Nogueira, Mauricio L.

Titel

Live, Attenuated, Tetravalent Butantan–Dengue Vaccine in Children and Adults

Ist Teil von

• The New England journal of medicine, 2024-02, Vol.390 (5), p.397-408

Ort / Verlag

United States: Massachusetts Medical Society

Erscheinungsjahr

2024

Link zum Volltext

Quelle

MEDLINE

Beschreibungen/Notizen

• Dengue outbreaks can affect 390 million persons yearly. In a trial involving 16,235 persons in Brazil, the live, attenuated, tetravalent Butantan vaccine was efficacious in all age groups at 2 years.